Chabiotech Co EBIT per Share
The EBIT per Share of Chabiotech Co (085660.KQ) as of Nov 1, 2026 is -521.06 KRW. In the previous year, EBIT per Share was 332.65 KRW — a change of -256.64% (lower).
Get this data via API
Financial Data API
EBIT per Share
-521.06KRW
YoY
-256.64%
Last updated:
The Chabiotech Co EBIT per Share history
3 Years
10 Years
25 Years
Max
| YEAR | EBIT per Share | YoY |
|---|---|---|
| -521.06KRW | -256.64% | |
| 332.65KRW | -345.79% | |
| -135.34KRW | -87.15% | |
| -1,053.55KRW | -898.46% | |
| 131.95KRW | -216.06% | |
| -113.69KRW | -237.17% | |
| 82.88KRW | -76.15% | |
| 347.45KRW | -360.12% | |
| -133.57KRW | -118.21% | |
| 733.44KRW | -138.27% | |
| -1,916.44KRW | -173.40% | |
| 2,610.89KRW | -75.71% | |
| 10,750.75KRW | +18.78% | |
| 9,050.76KRW | +161.64% | |
| 3,459.23KRW | +59.09% | |
| 2,174.39KRW | +42.65% | |
| 1,524.29KRW | +105.03% | |
| 743.45KRW | +7.79% | |
| 689.74KRW | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Chabiotech Co Stock analysis
Frequently Asked Questions about Chabiotech Co stock
EBIT per Share of Chabiotech Co is -521.06 KRW in 2025.
EBIT per Share of Chabiotech Co changed from 332.65 KRW to -521.06 KRW, representing a -256.64% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Chabiotech Co since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Chabiotech Co
All Key Metrics — Chabiotech Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth